# Allo - Cancer - Thrombosis

> **NCT03563924** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 100 (estimated)

## Conditions studied

- Cancer
- Venous Thromboembolism

## Interventions

- **OTHER:** Setting up a specific care path "AlloTC" for management of TVE in patients with cancer

## Key facts

- **NCT ID:** NCT03563924
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2018-12
- **Final completion:** 2019-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563924, "Allo - Cancer - Thrombosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03563924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*